Angiotensin (1-7): Applied Protocols and Troubleshooting Ins
2026-05-25
Angiotensin (1-7), the Mas receptor agonist, offers multi-system research advantages as an anti-fibrotic and anti-inflammatory agent. This article delivers practical, data-driven guidance for experimental design, protocol optimization, and troubleshooting with APExBIO's high-purity Angiotensin (1-7), including actionable workflow enhancements inspired by recent mechanistic breakthroughs.
Paroxetine Mesylate: Mechanisms, Targets, and Research Appli
2026-05-24
Paroxetine Mesylate is a selective serotonin reuptake inhibitor with multi-target kinase and cytochrome P450 inhibitory activity. It serves as both a clinical antidepressant and a versatile research tool in oncology, neurology, and kinase biology. Evidence supports its molecular actions on SERT, CYP2D6, GRK2, MET, and ERBB3.
Dihydrotestosterone: Precision Tools Against Anti-Androgen R
2026-05-23
This article explores how Dihydrotestosterone (DHT) enables translational researchers to dissect androgen receptor and EGFR/ERBB2 signaling, providing mechanistic and strategic insight into overcoming anti-androgen resistance in advanced prostate cancer. We blend biological rationale, experimental protocols, and competitive context, connecting recent discoveries—such as ECM1-driven MAPK activation—with actionable guidance for bridging preclinical models to future therapies.
Zosuquidar (LY335979) in Multidrug Resistance Research: Appl
2026-05-22
Zosuquidar (LY335979) 3HCl from APExBIO empowers researchers to reverse multidrug resistance (MDR) in cancer models with high precision. This article delivers actionable protocols, troubleshooting wisdom, and practical insights for leveraging this potent P-glycoprotein inhibitor in both in vitro and in vivo contexts.
ARCA Cy5 EGFP mRNA (5-moUTP): Precision in mRNA Delivery Ass
2026-05-22
ARCA Cy5 EGFP mRNA (5-moUTP) empowers researchers to visualize, quantify, and optimize mRNA delivery and translation in mammalian cells with unmatched fluorescence fidelity and immune-evasive stability. Its dual-labeling and 5-methoxyuridine modification streamline workflows for localization and efficiency assays, distinguishing it as a gold-standard control in both fundamental and translational mRNA research.
PPM-18: Precision iNOS Expression Inhibition via NF-κB Block
2026-05-21
PPM-18 (N-(1,4-dihydro-1,4-dioxo-2-naphthalenyl)-benzamide) is a potent, selective inhibitor of inducible nitric oxide synthase (iNOS) expression. It acts by blocking NF-κB from binding the iNOS promoter, resulting in robust anti-inflammatory effects. This detailed dossier summarizes its mechanism, evidence, and optimized research applications.
Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO): Protocol
2026-05-21
The Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO) is designed to prevent protein degradation during extraction, especially for workflows requiring mass spectrometry compatibility. It is not suitable for metalloproteinase inhibition unless supplemented with EDTA. Use this product for robust protection against serine, cysteine, acid proteases, and aminopeptidases, but avoid in workflows mandating AEBSF.
2-NBDG Fluorescent Glucose Uptake Assays: Advanced Workflows
2026-05-20
2-NBDG enables rapid, quantitative glucose uptake analysis in live cells and tissues, empowering researchers to profile metabolic dynamics with exceptional sensitivity. This article translates recent breakthroughs and troubleshooting strategies into actionable protocols for diabetes and metabolism research.
ICG001: Advancing Wnt/β-Catenin Pathway Inhibition in Fibros
2026-05-20
Explore how ICG001, a selective Wnt/β-catenin pathway inhibitor, enables mechanistic dissection of fibrosis progression and EMT in disease models. This article uniquely examines protocol optimization and translational considerations for leveraging ICG001 in advanced research applications.
MitMAB in Organoid Research: Redefining Endocytosis Assays
2026-05-19
Explore the advanced role of MitMAB in dissecting endocytosis mechanisms within intestinal organoid models. This article delivers a deep scientific analysis and practical guidance for researchers seeking precise control over dynamin-dependent membrane trafficking.
Digestive Metabolomics of Withania somnifera: Implications f
2026-05-19
This study pioneers a detailed metabolomic analysis of Withania somnifera (ashwagandha) extracts under simulated digestive conditions, revealing compound-specific stability and transformation. The findings refine in vitro modeling approaches for botanical mixtures, enhancing translational relevance for research on bioactive natural products.
Asunaprevir (BMS-650032): Optimizing HCV RNA Replication Inh
2026-05-18
Asunaprevir (BMS-650032) empowers researchers with broad-spectrum, nanomolar HCV NS3 protease inhibition and robust performance in complex cell models. This guide details advanced workflows, cross-platform troubleshooting, and actionable insights for maximizing assay reliability in hepatitis C research.
2X HyperFusion High-Fidelity Master Mix: Precision for Cloni
2026-05-18
Harness ultra-high accuracy with the 2X HyperFusion High-Fidelity Master Mix for cloning, CRISPR, and immunogenomics workflows. Discover how its advanced proofreading polymerase and optimized buffer system overcome common PCR challenges and elevate the fidelity of your molecular assays.
Isoprinosine in Immunotherapy: Protocols, Workflows, and HHV
2026-05-17
Isoprinosine (inosine pranobex) is a clinically proven immunomodulatory agent, offering dual-action antiviral and immune-enhancing properties. Explore how its integration with mechanistic insights from herpesvirus research empowers more effective experimental workflows and troubleshooting for acute respiratory and herpesviral infections.
Live-Dead Cell Staining Kit I: Advanced Viability Profiling
2026-05-16
Explore the power of the Live-Dead Cell Staining Kit I (Calcein AM/PI) for mammalian cell viability assays, with a unique focus on its role in bone regeneration and osteoporotic microenvironments. Discover protocol insights and high-impact applications distinct from standard oncology workflows.
466 records 18/32 page Previous Next First page 上5页 1617181920 下5页 Last page